- |||||||||| LM-102 / LaNova Medicines Limited
Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Combination therapy, Monotherapy, Metastases: Study of LM-102 in Patients With Advance Solid Tumors (clinicaltrials.gov) - Mar 9, 2023
P1/2, N=11, Terminated,
N=265 --> 11 | Trial completion date: Jun 2025 --> Feb 2023 | Recruiting --> Terminated | Trial primary completion date: Mar 2025 --> Feb 2023; company adjusted strategy
- |||||||||| LM-102 / LaNova Medicines Limited
Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Metastases: Study of LM-102 in Subjects in Advanced Tumors (clinicaltrials.gov) - Oct 26, 2022
P1, N=9, Terminated,
N=265 --> 11 | Trial completion date: Jun 2025 --> Feb 2023 | Recruiting --> Terminated | Trial primary completion date: Mar 2025 --> Feb 2023; company adjusted strategy N=30 --> 9 | Trial completion date: Mar 2023 --> May 2022 | Recruiting --> Terminated | Trial primary completion date: Mar 2023 --> May 2022; Business strategy changed
- |||||||||| LM-102 / LaNova Medicines Limited
Enrollment open, Combination therapy, Monotherapy, Metastases: Study of LM-102 in Patients With Advance Solid Tumors (clinicaltrials.gov) - Nov 11, 2021
P1/2, N=265, Recruiting,
N=30 --> 9 | Trial completion date: Mar 2023 --> May 2022 | Recruiting --> Terminated | Trial primary completion date: Mar 2023 --> May 2022; Business strategy changed Not yet recruiting --> Recruiting
- |||||||||| LM-102 / LaNova Medicines Limited
Trial initiation date, Metastases: Study of LM-102 in Subjects in Advanced Tumors (clinicaltrials.gov) - Jun 21, 2021
P1, N=30, Recruiting,
Not yet recruiting --> Recruiting Initiation date: Dec 2020 --> Jun 2021
- |||||||||| LM-102 / LaNova Medicines Limited
Enrollment open, Metastases: Study of LM-102 in Subjects in Advanced Tumors (clinicaltrials.gov) - May 19, 2021
P1, N=30, Recruiting,
Initiation date: Dec 2020 --> Jun 2021 Active, not recruiting --> Recruiting
- |||||||||| LM-102 / LaNova Medicines Limited
Enrollment closed, Trial initiation date, Metastases: Study of LM-102 in Subjects in Advanced Tumors (clinicaltrials.gov) - Apr 20, 2021
P1, N=30, Active, not recruiting,
Active, not recruiting --> Recruiting Not yet recruiting --> Active, not recruiting | Initiation date: Mar 2021 --> Dec 2020
|
